Anticoagulation Therapy in Endovascular Thrombectomy Patients With Large‐Vessel Occlusion Caused by Cardioembolism
Background In patients with ischemic stroke, cardioembolism, predominantly caused by atrial fibrillation (AF), is a leading preventable cause of large‐vessel occlusion (LVO). Despite proven efficacy, inadequate oral anticoagulant (OAC) therapy continues to be a major problem in patients with AF, mec...
Main Authors: | Jae Beom Hong, William K. Diprose, Michael T. M. Wang, Peter Alan Barber |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-03-01
|
Series: | Stroke: Vascular and Interventional Neurology |
Online Access: | https://www.ahajournals.org/doi/10.1161/SVIN.121.000175 |
Similar Items
-
Endovascular therapy in patients with large vessel occlusion due to cardioembolism large-artery atherosclerosis
by: Meredeth Zotter, et al.
Published: (2021-03-01) -
Sodium Levels and Outcomes Following Endovascular Thrombectomy for Ischemic Stroke
by: Jae Beom Hong, et al.
Published: (2022-07-01) -
Bypass of Primary Stroke Centers Compared With Secondary Transfer for Endovascular Thrombectomy
by: Jae Beom Hong, et al.
Published: (2022-11-01) -
Hospital Cost for Transferred Patients With Large Vessel Occlusions Undergoing Endovascular Thrombectomy
by: Joshua S. Catapano, et al.
Published: (2023-01-01) -
Cost-effectiveness of endovascular thrombectomy with alteplase versus endovascular thrombectomy alone for acute ischemic stroke secondary to large vessel occlusion
by: Ye, Z, et al.
Published: (2023)